Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
10
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | Director | 17 | $356.2K | $0 | 2025-05-30 |
| Amit Sharma | Director | 3 | $0 | $0 | 2025-05-30 |
| GRAY WILLIAM GARRETT | See Remarks | 26 | $0 | $1.79M | 2025-05-30 |
| Oliviero James F III | CEO, President and Director | 42 | $0 | $4.34M | 2025-05-30 |
| SALZMAN BARRY M | Director | 12 | $0 | $0 | 2025-05-30 |
| Fortress Biotech, Inc. | 10% Owner | 15 | $0 | $129.0K | 2025-05-30 |
| Bechon Christian | Director | 10 | $0 | $0 | 2025-05-30 |
| Herskowitz Neil | Director | 13 | $0 | $0 | 2025-05-30 |
| WEISS MICHAEL S | Director | 13 | $0 | $0 | 2025-05-30 |
| Boilen Scott | Director | 7 | $0 | $0 | 2023-06-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10% Owner | D To issuer deriv | 2025-05-30 | 2025-06-03 | 700,000 | — | $0 | 0 | SEC↗ |
| Amit Sharma | Director | U Tender | 2025-05-30 | 2025-05-30 | 94,246 | — | $0 | 0 | SEC↗ |
| Bechon Christian | Director | U Tender | 2025-05-30 | 2025-05-30 | 141,718 | — | $0 | 0 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | U Tender | 2025-05-30 | 2025-05-30 | 1,446,322 | — | $0 | 0 | SEC↗ |
| Herskowitz Neil | Director | U Tender | 2025-05-30 | 2025-05-30 | 147,007 | — | $0 | 0 | SEC↗ |
| Oliviero James F III | CEO, President and Director | U Tender | 2025-05-30 | 2025-05-30 | 3,759,929 | — | $0 | 0 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | U Tender | 2025-05-30 | 2025-05-30 | 207,007 | — | $0 | 0 | SEC↗ |
| SALZMAN BARRY M | Director | U Tender | 2025-05-30 | 2025-05-30 | 147,007 | — | $0 | 0 | SEC↗ |
| WEISS MICHAEL S | Director | U Tender | 2025-05-30 | 2025-05-30 | 187,007 | — | $0 | 0 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | D To issuer | 2025-05-30 | 2025-06-03 | 6,122,249 | $4.10 | $25.10M | 0 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2025-05-29 | 2025-05-30 | 50,000 | $1.29 | $64.5K | 207,007 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2025-05-29 | 2025-05-30 | 50,000 | $1.29 | $64.5K | 187,007 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | S Sale | 2025-05-29 | 2025-06-03 | 100,000 | $1.29 | $129.0K | 6,122,249 | SEC↗ |
| Amit Sharma | Director | A Award | 2025-05-28 | 2025-05-30 | 12,195 | — | $0 | 94,246 | SEC↗ |
| Bechon Christian | Director | A Award | 2025-05-28 | 2025-05-30 | 12,195 | — | $0 | 141,718 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2025-05-28 | 2025-05-30 | 12,195 | — | $0 | 147,007 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2025-05-28 | 2025-05-30 | 12,195 | — | $0 | 157,007 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2025-05-28 | 2025-05-30 | 12,195 | — | $0 | 147,007 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2025-05-28 | 2025-05-30 | 12,195 | — | $0 | 137,007 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2025-04-02 | 2025-04-03 | 15,090 | $4.04 | $61.0K | 3,759,929 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2025-04-01 | 2025-04-03 | 12,322 | $4.05 | $49.9K | 1,446,322 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2025-02-26 | 2025-02-27 | 18,500 | — | $0 | 6,222,249 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2025-02-10 | 2025-02-11 | 10,331 | $3.15 | $32.5K | 3,775,019 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2025-02-07 | 2025-02-11 | 9,233 | $3.41 | $31.5K | 3,785,350 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2025-02-06 | 2025-02-07 | 74,110 | $3.67 | $272.0K | 1,458,644 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2025-01-30 | 2025-01-31 | 1,500,000 | — | $0 | 3,794,583 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | A Award | 2025-01-30 | 2025-01-31 | 500,000 | — | $0 | 1,532,754 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2025-01-01 | 2025-01-03 | 2,386,808 | — | $0 | 6,203,749 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2024-12-31 | 2025-01-03 | 81,407 | — | $0 | 3,816,941 | SEC↗ |
| Oliviero James F III | CEO, President and Director | G Gift | 2024-12-20 | 2024-12-20 | 900,000 | — | $0 | 2,294,583 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2024-12-19 | 2024-12-20 | 220,230 | $3.38 | $744.4K | 3,194,583 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2024-12-18 | 2024-12-20 | 268,432 | $4.01 | $1.08M | 1,032,754 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2024-12-18 | 2024-12-20 | 602,167 | $3.87 | $2.33M | 3,414,813 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2024-12-13 | 2024-12-17 | 17,638 | — | $0 | 134,812 | SEC↗ |
| Bechon Christian | Director | A Award | 2024-12-13 | 2024-12-17 | 14,994 | — | $0 | 129,523 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | A Award | 2024-12-13 | 2024-12-17 | 629,000 | — | $0 | 1,301,186 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2024-12-13 | 2024-12-17 | 2,077,700 | — | $0 | 4,016,980 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2024-12-13 | 2024-12-17 | 12,638 | — | $0 | 144,812 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2024-12-13 | 2024-12-17 | 17,638 | — | $0 | 134,812 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2024-12-13 | 2024-12-17 | 12,638 | — | $0 | 124,812 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2024-09-27 | 2024-10-01 | 146,341 | — | $0 | 3,735,534 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2024-06-26 | 2024-06-28 | 13,038 | $2.06 | $26.9K | 672,186 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2024-06-26 | 2024-06-28 | 24,610 | $2.05 | $50.5K | 1,977,170 | SEC↗ |
| Oliviero James F III | CEO, President and Director | G Gift | 2024-06-26 | 2024-06-28 | 37,890 | — | $0 | 1,939,280 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2024-05-24 | 2024-05-24 | 1,660,000 | — | $0 | 2,001,780 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | A Award | 2024-05-24 | 2024-05-24 | 540,000 | — | $0 | 685,224 | SEC↗ |
| Bechon Christian | Director | A Award | 2024-05-14 | 2024-05-16 | 32,051 | — | $0 | 64,529 | SEC↗ |
| Bechon Christian | Director | A Award | 2024-05-14 | 2024-05-16 | 50,000 | — | $0 | 114,529 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2024-05-14 | 2024-05-16 | 32,051 | — | $0 | 67,174 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2024-05-14 | 2024-05-16 | 50,000 | — | $0 | 117,174 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2024-05-14 | 2024-05-16 | 50,000 | — | $0 | 132,174 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2024-05-14 | 2024-05-16 | 32,051 | — | $0 | 82,174 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2024-05-14 | 2024-05-16 | 32,051 | — | $0 | 67,174 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2024-05-14 | 2024-05-16 | 50,000 | — | $0 | 117,174 | SEC↗ |
| Amit Sharma | Director | A Award | 2024-05-14 | 2024-05-16 | 32,051 | — | $0 | 82,051 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2024-05-14 | 2024-05-16 | 50,000 | — | $0 | 112,174 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2024-05-14 | 2024-05-16 | 32,051 | — | $0 | 62,174 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2024-03-20 | 2024-03-22 | 193,905 | — | $0 | 2,096,278 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2024-02-28 | 2024-03-01 | 2,035 | $2.07 | $4.2K | 145,224 | SEC↗ |
| Oliviero James F III | CEO, President and Director | G Gift | 2024-02-28 | 2024-03-01 | 9,056 | — | $0 | 341,780 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2024-02-28 | 2024-03-01 | 5,894 | $2.06 | $12.1K | 350,836 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2024-02-01 | 2024-02-02 | 11,900 | $2.01 | $23.9K | 369,680 | SEC↗ |
| Oliviero James F III | CEO, President and Director | G Gift | 2024-02-01 | 2024-02-02 | 12,950 | — | $0 | 356,730 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2024-02-01 | 2024-02-02 | 4,115 | $1.95 | $8.0K | 147,259 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-12-29 | 2024-01-03 | 158,134 | — | $0 | 1,902,373 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-09-25 | 2023-09-26 | 80,906 | — | $0 | 1,744,239 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-06-30 | 2023-07-03 | 81,406 | — | $0 | 1,663,333 | SEC↗ |
| Bechon Christian | Director | A Award | 2023-06-13 | 2023-06-15 | 17,483 | — | $0 | 32,478 | SEC↗ |
| Boilen Scott | Director | A Award | 2023-06-13 | 2023-06-15 | 17,483 | — | $0 | 37,345 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2023-06-13 | 2023-06-15 | 17,483 | — | $0 | 35,123 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2023-06-13 | 2023-06-15 | 17,483 | — | $0 | 50,123 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2023-06-13 | 2023-06-15 | 17,483 | — | $0 | 35,123 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2023-06-13 | 2023-06-15 | 17,483 | — | $0 | 30,123 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-04-04 | 2023-04-04 | 42,500 | — | $0 | 1,581,927 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-03-31 | 2023-04-04 | 35,714 | — | $0 | 1,539,427 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | A Award | 2023-03-31 | 2023-04-04 | 100,000 | — | $0 | 151,374 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2023-03-31 | 2023-04-04 | 250,000 | — | $0 | 394,090 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2023-03-02 | 2023-03-03 | 3,591 | $5.00 | $18.0K | 51,374 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2023-03-02 | 2023-03-03 | 5,483 | $5.00 | $27.4K | 144,090 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2023-02-27 | 2023-03-03 | 1,914 | $4.66 | $8.9K | 47,465 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | A Award | 2023-02-27 | 2023-03-03 | 7,500 | — | $0 | 54,965 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2023-02-27 | 2023-03-03 | 5,548 | $4.65 | $25.8K | 134,573 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2023-02-27 | 2023-03-03 | 15,000 | — | $0 | 149,573 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2023-02-01 | 2023-02-03 | 10,261 | $4.77 | $48.9K | 182,121 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2023-02-01 | 2023-02-03 | 3,154 | $4.79 | $15.1K | 49,379 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2023-01-10 | 2023-01-12 | 3,817 | $6.75 | $25.8K | 192,382 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2023-01-10 | 2023-01-12 | 1,858 | $6.75 | $12.5K | 52,533 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-01-05 | 2023-01-06 | 368,907 | — | $0 | 1,503,713 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2022-06-23 | 2022-07-01 | 15,000 | $1.11 | $16.6K | 2,562,003 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2022-06-22 | 2022-07-01 | 12,000 | $1.09 | $13.1K | 2,577,003 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2022-06-21 | 2022-07-01 | 21,000 | $1.09 | $22.9K | 2,589,003 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2022-06-17 | 2022-07-01 | 228,000 | $1.09 | $248.5K | 2,610,003 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2022-06-16 | 2022-06-24 | 47,619 | — | $0 | 126,401 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2022-06-16 | 2022-06-24 | 47,619 | — | $0 | 176,401 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2022-06-16 | 2022-06-24 | 47,619 | — | $0 | 326,401 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2022-06-16 | 2022-06-24 | 47,619 | — | $0 | 176,401 | SEC↗ |
| Boilen Scott | Director | A Award | 2022-06-16 | 2022-06-24 | 47,619 | — | $0 | 198,621 | SEC↗ |
| Bechon Christian | Director | A Award | 2022-06-16 | 2022-06-24 | 47,619 | — | $0 | 149,953 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2022-04-13 | 2022-04-22 | 21,258 | $1.51 | $32.1K | 2,838,003 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2022-04-05 | 2022-04-22 | 14,030 | $1.77 | $24.8K | 2,859,261 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2022-04-04 | 2022-04-22 | 86,353 | $1.79 | $154.6K | 2,873,291 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2022-03-10 | 2022-03-11 | 38,197 | $1.89 | $72.2K | 543,910 | SEC↗ |
| Oliviero James F III | CEO, President and Director | F Tax w/h | 2022-02-24 | 2022-04-22 | 117,657 | $1.85 | $217.7K | 2,959,644 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2022-02-01 | 2022-02-02 | 37,063 | $2.51 | $93.0K | 582,107 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2022-01-31 | 2022-02-02 | 455,000 | — | $0 | 3,608,210 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | A Award | 2022-01-31 | 2022-02-02 | 137,000 | — | $0 | 619,170 | SEC↗ |
| Oliviero James F III | CEO, President and Director | F Tax w/h | 2022-01-30 | 2022-04-22 | 31,972 | $2.46 | $78.7K | 3,077,301 | SEC↗ |
| Oliviero James F III | CEO, President and Director | F Tax w/h | 2022-01-24 | 2022-04-22 | 143,136 | $2.19 | $313.5K | 3,109,273 | SEC↗ |
| Oliviero James F III | CEO, President and Director | F Tax w/h | 2022-01-06 | 2022-04-22 | 53,024 | $2.77 | $146.9K | 3,252,409 | SEC↗ |
| Oliviero James F III | CEO, President and Director | F Tax w/h | 2022-01-01 | 2022-04-22 | 302,777 | $3.11 | $941.6K | 3,305,433 | SEC↗ |
| Bechon Christian | Director | A Award | 2021-06-10 | 2021-06-11 | 16,502 | — | $0 | 102,334 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2021-06-10 | 2021-06-11 | 16,502 | — | $0 | 128,782 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2021-06-10 | 2021-06-11 | 16,502 | — | $0 | 278,782 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2021-06-10 | 2021-06-11 | 16,502 | — | $0 | 128,782 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2021-06-10 | 2021-06-11 | 16,502 | — | $0 | 78,782 | SEC↗ |
| Boilen Scott | Director | A Award | 2021-06-10 | 2021-06-11 | 16,502 | — | $0 | 151,004 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2021-02-05 | 2021-02-05 | 48,790 | $3.42 | $166.9K | 3,153,210 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2021-02-04 | 2021-02-05 | 26,320 | $3.66 | $96.3K | 482,170 | SEC↗ |
| Oliviero James F III | CEO, President and Director | S Sale | 2021-02-04 | 2021-02-05 | 70,000 | $3.51 | $245.7K | 3,202,000 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | A Award | 2021-01-06 | 2021-01-08 | 151,000 | — | $0 | 508,490 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2021-01-06 | 2021-01-08 | 539,000 | — | $0 | 3,272,000 | SEC↗ |
| GRAY WILLIAM GARRETT | Chief Financial Officer | S Sale | 2020-12-22 | 2020-12-23 | 2,406 | $2.79 | $6.7K | 357,490 | SEC↗ |
| Bechon Christian | Director | A Award | 2020-06-05 | 2020-06-09 | 24,390 | — | $0 | 85,832 | SEC↗ |
| Boilen Scott | Director | A Award | 2020-06-05 | 2020-06-09 | 24,390 | — | $0 | 134,502 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2020-06-05 | 2020-06-09 | 24,390 | — | $0 | 112,280 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2020-06-05 | 2020-06-09 | 24,390 | — | $0 | 112,280 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2020-06-05 | 2020-06-09 | 24,390 | — | $0 | 62,280 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2020-06-05 | 2020-06-09 | 24,390 | — | $0 | 262,280 | SEC↗ |
| GRAY WILLIAM GARRETT | See Remarks | S Sale | 2020-05-21 | 2020-05-22 | 17,104 | $2.00 | $34.2K | 359,896 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2020-02-24 | 2020-02-25 | 598,000 | — | $0 | 2,733,000 | SEC↗ |
| GRAY WILLIAM GARRETT | See Remarks | A Award | 2020-02-24 | 2020-02-25 | 157,000 | — | $0 | 377,000 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2019-11-20 | 2019-11-22 | 100,000 | $1.27 | $127.0K | 237,890 | SEC↗ |
| Bechon Christian | Director | A Award | 2019-06-13 | 2019-06-14 | 11,442 | — | $0 | 61,442 | SEC↗ |
| Boilen Scott | Director | A Award | 2019-06-13 | 2019-06-14 | 11,442 | — | $0 | 110,112 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2019-06-13 | 2019-06-14 | 11,442 | — | $0 | 87,890 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2019-06-13 | 2019-06-14 | 11,442 | — | $0 | 137,890 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2019-06-13 | 2019-06-14 | 11,442 | — | $0 | 87,890 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2019-06-13 | 2019-06-14 | 11,442 | — | $0 | 37,890 | SEC↗ |
| Oliviero James F III | CEO, President and Director | A Award | 2019-01-24 | 2019-01-25 | 485,000 | — | $0 | 2,135,000 | SEC↗ |
| GRAY WILLIAM GARRETT | See Remarks | A Award | 2019-01-24 | 2019-01-25 | 90,000 | — | $0 | 220,000 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-11-09 | 2018-11-13 | 49,666 | $2.35 | $116.7K | 126,448 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-11-08 | 2018-11-13 | 48,234 | $2.24 | $108.0K | 76,782 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-11-07 | 2018-11-13 | 2,100 | $2.12 | $4.5K | 28,548 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2018-06-14 | 2018-06-15 | 16,448 | — | $0 | 26,448 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2018-06-14 | 2018-06-15 | 16,448 | — | $0 | 76,448 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2018-06-14 | 2018-06-15 | 16,448 | — | $0 | 26,448 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2018-06-14 | 2018-06-15 | 16,448 | — | $0 | 76,448 | SEC↗ |
| Boilen Scott | Director | A Award | 2018-06-14 | 2018-06-15 | 16,448 | — | $0 | 98,670 | SEC↗ |
| GRAY WILLIAM GARRETT | See Remarks | A Award | 2018-01-30 | 2018-02-01 | 50,000 | — | $0 | 130,000 | SEC↗ |
| Oliviero James F III | CEO and President | A Award | 2018-01-30 | 2018-02-01 | 325,000 | — | $0 | 1,650,000 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award | 2017-07-10 | 2017-07-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Boilen Scott | Director | A Award | 2017-06-15 | 2017-06-15 | 10,000 | — | $0 | 82,222 | SEC↗ |
| SALZMAN BARRY M | Director | A Award | 2017-06-15 | 2017-06-15 | 10,000 | — | $0 | 60,000 | SEC↗ |
| WEISS MICHAEL S | Director | A Award | 2017-06-15 | 2017-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2017-06-15 | 2017-06-15 | 10,000 | — | $0 | 60,000 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2017-03-17 | 2017-06-07 | 721,699 | — | $0 | 2,702,705 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2017-01-13 | 2017-01-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Oliviero James F III | CEO and President | A Award | 2016-12-15 | 2016-12-19 | 325,000 | — | $0 | 1,325,000 | SEC↗ |